Women with pathologic stage I, II, and III non-small cell lung cancer have better survival than men

Chest

Volumn 130, Issue 6, 2006, Pages 1796-1802

  Cerfolio, Robert James ^a   Bryant, Ayesha S ^a   Scott, Ethan ^e   Sharma, Manisha ^e   Robert, Francisco ^b   Spencer, Sharon A ^d   Garver, Robert I ^c  

^a Kentucky   (United States)

^b University of Alabama at Birmingham   (United States)

^c UNIVERSITY OF ALABAMA AT BIRMINGHAM   (United States)

^d The University of Alabama at Birmingham   (United States)

^e UNIVERSITY OF ALABAMA SCHOOL OF MEDICINE   (United States)

Author keywords

Lung cancer; Staging; Surgery

Indexed keywords

PLATINUM DERIVATIVE;

ADULT; AGE; AGED; ALGORITHM; ARTICLE; CANCER ADJUVANT THERAPY; CANCER CHEMOTHERAPY; CANCER RADIOTHERAPY; CANCER REGISTRY; CANCER STAGING; CANCER SURVIVAL; COHORT ANALYSIS; DIAGNOSTIC IMAGING; DRUG RESPONSE; EVALUATION; FEMALE; FOLLOW UP; GENDER; HUMAN; LUNG ADENOCARCINOMA; LUNG NON SMALL CELL CANCER; MAJOR CLINICAL STUDY; MALE; OUTCOME ASSESSMENT; POSITRON EMISSION TOMOGRAPHY; PRIORITY JOURNAL; PROSPECTIVE STUDY; RISK FACTOR; SEX DIFFERENCE; SURVIVAL RATE; SURVIVAL TIME;

EID: 33845944307     PISSN: 00123692     EISSN: None     Source Type: Journal    
DOI: 10.1378/chest.130.6.1796     Document Type: Article

References (30)

1. Jemal A, Murray T, Samuels A, et al. Cancer statistics, 2003. CA Cancer J Clin 2003; 53:5-26
2. Thun MJ. Cancer facts & figures 2004. Atlanta, GA: American Cancer Society, 2004
3. Visbal AL, Williams BA, Nichols FC, et al. Gender differences in non-small cell lung cancer survival: an analysis of 4,618 patients diagnosed between 1997 and 2002. Ann Thorac Surg 2004; 78:209-215
4. Ferguson MF, Skosey C, Hoffman PC, et al. Sex-associated differences in presentation and survival in patients with lung cancer. J Clin Oncol 1990; 8:1402-1407
5. Agudo A, Ahrens W, Benhamou E, et al. Lung cancer and cigarette smoking in women: a multi-center case control study in Europe. Int J Cancer 2000; 88:820-827
6. Radzikowska E, Glaz P, Roszkowski K. Lung cancer in women: age, smoking, histology, performance status, stage, initial treatment and survival: population-based study of 20,561 cases. Ann Oncol 2002; 13:1087-1093
7. McDuffie H, Klaassen D, Dosman J, et al. Female-male differences in patients with primary lung cancer. Cancer 1987; 59:1825-1830
8. Cerfolio RJ, Bryant AS, Buddhiwardan O, et al. Improving the inaccuracies of clinical staging of patients with NSCLC: a prospective trial. Ann Thorac Surg 2005; 80:1207-1214
9. Eloubedi MA, Cerfolio RJ, Chen VK, et al. Endoscopic ultrasound guided fine needle aspiration of mediastinal lymph node in patients with suspected lung cancer after positron emission tomography and computed tomography scans. Ann Thorac Surg 2005; 79:263-268
10. Mountain CF. Revisions in the International Systems for Staging Lung Cancer. Chest 1997; 111:1710-1717
11. Devesa SS, Bray F, Vizacaino AP, et al. International lung cancer trends by histologic type: male:female differences diminishing and adenocarcinoma rates rising. Int J Cancer 2005; 117:294-299
12. Fu JB, Kau TY, Severson RK, et al. Lung cancer in women: analysis of the national Surveillance, Epidemiology, and End Results database. Chest 2005; 127:768-777
13. International Adjuvant Lung Cancer Trial Collaborative Group. Cisplatin-based adjuvant chemotherapy in patients with completely resected non-small-cell lung cancer. N Engl J Med 2004; 350:351-360
14. Alexiou C, Onyeaka CV, Beggs D, et al. Do women live longer following lung resection for carcinoma? Eur J Cardiothorac Surg 2002; 21:319-325
15. Minami H, Yoshida T, Okutsu K, et al. Lung cancer treated surgically in patients <50 years of age. Chest 2001; 120:32-36
16. Stabile LP, Davis AL, Gubish CT, et al. Human non-small cell lung tumors and cell derived from normal lung express both estrogen receptor α and β and show biological responses to estrogen. Cancer Res 2002; 62:2141-2150
17. Canver CC, Memoli VA, Vanderveer PL, et al. Sex hormone receptors in non-small cell lung cancer in human beings. J Thorac Cardiovasc Surg 1994; 108:153-157
18. Olak J, Colson Y. Gender differences in lung cancer: have we really come a long way, baby? J Thorac Cardiovasc Surg 2004; 128:346-351
19. Janne PA, Gurubhagabatula S, Yeap BY, et al. Outcomes of patients with advanced non-small cell lung cancer treated with gefitinib (Iressa) on an expanded access study. Lung Cancer 2004; 44:221-230
20. Keller SM, Vangel MG, Adak S, et al. The influence of gender on survival and tumor recurrence following adjuvant therapy for completely resected stages II and IIIa non-small cell lung cancer. Lung Cancer 2002; 37:303-309
21. Cerfolio RJ, Bryant AS, Ohja B. The maximum standardized uptake values on positron emission tomography of a non-small cell lung cancer predict stage, recurrence and survival. J Thorac Cardiovasc Surg 2005; 130:151-159
22. Cerfolio RJ, Bryant AS, Winokur TS, et al. Repeat FDG-PET after neoadjuvant therapy is a predictor of pathologic response in patients with non-small cell lung cancer. Ann Thorac Surg 2004; 78:1903-1909
23. Chatkin JM, Abreu CM, Fritscher CC, et al. Is there a gender difference in non-small cell lung cancer survival? Gend Med 2004; 1:41-47
24. Ferguson MK, Wang J, Hoffman PC. Sex-associated differences in survival of patients undergoing resection for lung cancer. Ann Thorac Surg 69:245-250
25. Ryberg D, Hewe A, Phillips DH, et al. Different susceptibility to smoking-induced DNA damage among male and female lung cancer patients. Cancer Res 1994; 54:5801-5803
26. Kure EH, Ryberg D, Hewer A, et al. p53 mutations in lung tumours: relationship to gender and lung DNA adduct levels. Carcinogenesis 1996; 17:2201-2205
27. Ahrendt SA, Decker PA, Alawi EA, et al. Cigarette smoking is strongly associated with mutation of the K-ras gene in patients with primary adenocarcinorna of the lung. Cancer 2001; 92:1525-1530
28. Hirayasu T, Iwamasa T, Kamada Y, et al. Human papilloma virus DNA in squamous cell carcinoma of the lung. J Clin Pathol 1996; 49:810-817
29. Yousem SA, Ohori, Sonmez-Alpan E. Occurrence of human papillomavirus DNA in primary lung neoplasms. Cancer 1992; 69:693-697
30. Albain KS, Rusch VW, Crowley JJ. Concurrent cisplatin/ etoposide plus chest radiotherapy followed by surgery for stages IIIA (N2) and IIIB non-small cell lung cancer: mature results of the Southwest Oncology Group phase II study 8805. J Clin Oncol 1995; 13:1880-1992